Cart
sales@molnova.com
Glycyl-glycine
CAS No. 556-50-3
Glycyl-glycine( Diglycine | Diglycocoll | Glycine dipeptide | N-Glycylglycine | Gly-gly )
Catalog No. M20028 CAS No. 556-50-3
Glycylglycine (Gly-Gly) is a dipeptide used in biochemical research. It is the simplest of all dipeptides and is used as a starting template for preparation of more complex peptides. Glycine is involved in the body's production of DNA phospholipids and collagen and in the release of energy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 38 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGlycyl-glycine
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlycylglycine (Gly-Gly) is a dipeptide used in biochemical research. It is the simplest of all dipeptides and is used as a starting template for preparation of more complex peptides. Glycine is involved in the body's production of DNA phospholipids and collagen and in the release of energy.
-
DescriptionGlycylglycine (Gly-Gly) is a dipeptide used in biochemical research. It is the simplest of all dipeptides and is used as a starting template for preparation of more complex peptides. Glycine is involved in the body's production of DNA phospholipids and collagen and in the release of energy.
-
In Vitro——
-
In Vivo——
-
SynonymsDiglycine | Diglycocoll | Glycine dipeptide | N-Glycylglycine | Gly-gly
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number556-50-3
-
Formula Weight132.12
-
Molecular FormulaC4H8N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 130 mg/mL (983.95 mM)
-
SMILESNCC(=O)NCC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Van Hove JL et al. Benzoate treatment and the glycine index in nonketotic hyperglycinaemia. J Inherit Metab Dis. 2005;28(5):651-63.
molnova catalog
related products
-
Burosumab
Burosumab(KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
-
CM 346
Afobazole (CM346) is an anxiolytic drug; produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions.
-
Polatuzumab
Polatuzumab is a monoclonal antibody that targets CD79b and carries chemotherapeutically active molecules.Polatuzumab adheres to CD79b proteins and transports the chemotherapeutically active molecules into cells to kill them.
